Sodium Amidotrizoate / Meglumine Amidotrizoate
Therapeutic agent (verify pharmacological class)
What it is used for
Visualization of various body cavities: retrograde urography (RUG), endoscopic retrograde cholangiopancreatography (ERCP), percutaneous transhepatic cholangiography (PTC), arthrography, (ptyalography) galactography, and fistulography. Children and neonates, drip-infusion urography: Max. dose, 4 ml/kg body weight.
Warnings
Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.